doi：10.3969/j.issn.1007-614x.2014.18.27

    摘要目的：探讨拉米夫定联合阿德福韦酯治疗乙肝肝硬化的效果。方法：2012年10月-2013年12月收治乙肝肝硬化患者112例，随机分为研究组和对照组各56例，研究组予以拉米夫定联合阿德福韦酯，对照组单纯予以拉米夫定，分析两组的临床治疗结果。结果：治疗后研究组的HBV-DNA、ALT、ALB水平明显优于对照组，且临床症状改善情况明显高于对照组，比较差异具有统计学意义(P<0.05)。结论：拉米夫定联合阿德福韦酯治疗乙肝肝硬化效果显著。

    关键词乙肝肝硬化拉米夫定阿德福韦酯

    Study on the effect of lamivudine combined with adefovir dipivoxil in the treatment of hepatitis B cirrhosis

    Liu Zhaoyang

    The First Department of Liver，the Fifth People’s Hospital of Anyang City，Henan 455000

    AbstractObjective：To explore the effect of lamivudine combined with adefovir dipivoxil in the treatment of hepatitis B cirrhosis. Methods：112 cases with hepatitis B cirrhosis were selected from October 2012 to December 2013.They were randomly divided into the study group and the control group with 56 cases in each.The study group were treated with the combination of lamivudine and adefovir dipivoxil ......